Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A Hebert

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Arthritis Care & Research|September 6, 2012
High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosusChi Chiu Mok, Daniel J Birmingham, Ling Yin Ho, et al.
Bulletin of the NYU Hospital for Joint Diseases|October 10, 2007
Biomarker discovery in human SLE nephritisBrad H Rovin, Daniel J Birmingham, Haikady N Nagaraja, et al.
Archives of Pathology & Laboratory Medicine|June 7, 2007
Typing of amyloidosis in renal biopsies: diagnostic pitfallsAnjali A Satoskar, Kelly Burdge, Daniel J Cowden, et al.
Nephron. Clinical Practice|August 13, 2009
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patientsLee A Hebert, Daniel J Birmingham, Ganesh Shidham, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 3, 2008
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implicationsDaniel J Birmingham, Brad H Rovin, Ganesh Shidham, et al.
Arthritis and Rheumatism|March 15, 2011
An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritisStacy Ardoin, Daniel J Birmingham, Paul L Hebert, et al.
Rheumatology (Oxford, England)|July 2, 2011
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosisChi Chiu Mok, Daniel J Birmingham, Hoi Wah Leung, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2003
Management of glomerular proteinuria: a commentaryWilliam A Wilmer, Brad H Rovin, Christopher J Hebert, et al.
Journal of the American Society of Nephrology : JASN|December 17, 2004
Urine chemokines as biomarkers of human systemic lupus erythematosus activityBrad H Rovin, Huijuan Song, Dan J Birmingham, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 5, 2009
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic optionAlison McKinley, Edward Park, Dan Spetie, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Arthritis Care & Research|September 6, 2012
High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosusChi Chiu Mok, Daniel J Birmingham, Ling Yin Ho, et al.
Bulletin of the NYU Hospital for Joint Diseases|October 10, 2007
Biomarker discovery in human SLE nephritisBrad H Rovin, Daniel J Birmingham, Haikady N Nagaraja, et al.
Archives of Pathology & Laboratory Medicine|June 7, 2007
Typing of amyloidosis in renal biopsies: diagnostic pitfallsAnjali A Satoskar, Kelly Burdge, Daniel J Cowden, et al.
Nephron. Clinical Practice|August 13, 2009
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patientsLee A Hebert, Daniel J Birmingham, Ganesh Shidham, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 3, 2008
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implicationsDaniel J Birmingham, Brad H Rovin, Ganesh Shidham, et al.
Arthritis and Rheumatism|March 15, 2011
An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritisStacy Ardoin, Daniel J Birmingham, Paul L Hebert, et al.
Rheumatology (Oxford, England)|July 2, 2011
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosisChi Chiu Mok, Daniel J Birmingham, Hoi Wah Leung, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2003
Management of glomerular proteinuria: a commentaryWilliam A Wilmer, Brad H Rovin, Christopher J Hebert, et al.
Journal of the American Society of Nephrology : JASN|December 17, 2004
Urine chemokines as biomarkers of human systemic lupus erythematosus activityBrad H Rovin, Huijuan Song, Dan J Birmingham, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 5, 2009
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic optionAlison McKinley, Edward Park, Dan Spetie, et al.
Pageof 8